[ Price : $8.95]
FDA grants an orphan drug designation to the controversial Burzynski Research Institute for its antineoplaston A10 and antineoplas...[ Price : $8.95]
FDA issues MedImmune a complete response letter on its BLA for motavizumab, indicated for preventing serious respiratory syncytial...[ Price : $8.95]
FDA upholds its reference-listed drug change policy in a case involving Osmoticas NDA for venlafaxine HCl extended-release tablets...[ Price : $8.95]
U.S. attorney Michael Sullivan says a medical device company manager pleaded guilty to making a false statement and misbranding.[ Price : $8.95]
Federal Register Notice: FDA releases a guidance, Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials.[ Price : $8.95]
FDA tells the Anti-infective Advisory Committee it sees mild to moderate adverse events in Novartis malaria drug Coartem.[ Price : $8.95]
Microtest Laboratories president Steven Richter says manufacturers of combination products will be challenged to keep up with incr...[ Price : $8.95]
Cephalon, Eurand, and Anesta AG file suit against Mylan Pharmaceuticals over its ANDA for a generic copy of muscle relaxant Amrix.